[Polaris Pharmaceuticals-KY] Announcement Regarding the Change of Audit Committee Convener

1. Date of change: May 25, 115 2. Name of the functional committee: Audit Committee 3. Name of the predecessor: Wei Zongde 4. Resume of the predecessor: Professor at China Medical University 5. Name of the successor: Zhang Zhigang 6. Resume of the successor: Zhang Zhigang / CEO of CellGenMed 7. Circumstances of change: Expiration of term 8. Reason for change: Expiration of term 9. Former term: 112/09/26 ~ 115/06/11 10. Effective date of the new appointment: May 25, 115 11. Other notes: Upon the recommendation of the Audit Committee members, committee member Zhang Zhigang was elected as the convener for this term.